NCT03055780

Brief Summary

The aim of this study was to determine the diagnostic accuracy of SURECardio CT-FFR to detect functionally significant coronary stenosis.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 14, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 16, 2017

Completed
Last Updated

February 16, 2017

Status Verified

February 1, 2017

Enrollment Period

11 months

First QC Date

February 14, 2017

Last Update Submit

February 14, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sensitivity and specificity of SURECardio CT-FFR to detect functionally significant coronary stenosis

    one day

Study Arms (1)

CT-FFR. CTA. FFR

59 patients with suspected CAD that have been scheduled for an interventional FFR study

Device: CT-FFR. CTA. FFR

Interventions

Study is to compare results of CT FFR against CTA and interventional FFR

CT-FFR. CTA. FFR

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Suspected coronary artery disease

You may qualify if:

  • suspected coronary artery disease
  • hemodynamically stable condition

You may not qualify if:

  • hemodynamic instability
  • atrial fibrillation
  • morbid obesity (BMI≥40 kg/m2)
  • previous stent implantation
  • recent myocardial infarction (within 30 days)
  • age \<40 years
  • renal insufficiency (eGFR \<60mL/min/1.73m2)
  • bronchospastic lung disease requiring long term steroid therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2017

First Posted

February 16, 2017

Study Start

July 1, 2015

Primary Completion

May 30, 2016

Study Completion

October 1, 2016

Last Updated

February 16, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share